[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100520837":3},{"organization":4,"outcomesModule":7,"designInfo":35,"detailedDescription":42,"studyPopulation":38,"armGroups":43,"interventions":54,"overallOfficials":60,"centralContacts":65,"locations":71,"responsibleParty":90,"collaborators":38,"id":92,"slug":38,"hasResults":93,"nctId":94,"briefTitle":95,"officialTitle":96,"acronym":38,"eligibilityCriteria":97,"healthyVolunteers":93,"sex":98,"minAge":99,"maxAge":100,"enrollmentInfo":101,"targetDuration":38,"studyType":104,"phases":105,"briefSummary":107,"conditions":108,"keywords":38,"overallStatus":74,"whyStopped":38,"lastUpdateSubmitDate":111,"lastUpdatePostDateStruct":112,"startDateStruct":115,"completionDateStruct":117,"leadSponsor":119,"locationsCount":120},{"fullName":5,"class":6},"Kansas City Heart Rhythm Research Foundation","OTHER",{"primaryOutcomes":8,"secondaryOutcomes":13,"otherOutcomes":27},[9],{"measure":10,"description":11,"timeFrame":12},"Success of Implantation of Left Atrial Appendage Closure (LAAC) device","Success of Implantation of Amulet or Watchman FLX device","1 Day",[14,17,19,22,25],{"measure":15,"description":16,"timeFrame":12},"Intraprocedural measurements","Transeptal access view, LAA thrombus, Stability of the device, Peri-device leaks, Device Repositioning, Clarity of mitral valve or pulmonary vein impingement will be noted as Yes\u002FNo from Echocardiogram",{"measure":15,"description":18,"timeFrame":12},"LAA size in different sites will be noted from Echocardiograms",{"measure":20,"description":21,"timeFrame":12},"Intraprocedural measurements - LAA device size","LAA device size will be measured based on the LAA size",{"measure":23,"description":24,"timeFrame":12},"Location of the leaks","Location of the leaks will be identified",{"measure":15,"description":26,"timeFrame":12},"Procedural duration, Fluoroscopic time",[28,32],{"measure":29,"description":30,"timeFrame":31},"Post Procedural Outcomes","Presence of any Peri-device leaks (PDL), Device Related Thrombus (DRTs), Micro migration and device tilt will be noted.","45 Days, 6 Months and 12 Months",{"measure":33,"description":34,"timeFrame":31},"Post Procedural Outcomes - Size of the leaks","Leaks if any, leaks size will be measured",{"allocation":36,"interventionModel":37,"interventionModelDescription":38,"primaryPurpose":39,"observationalModel":38,"timePerspective":38,"maskingInfo":40},"NON_RANDOMIZED","PARALLEL",null,"SUPPORTIVE_CARE",{"masking":41,"maskingDescription":38,"whoMasked":38},"NONE","Standard intraprocedural guidance for transcatheter left atrial appendage closure (LAAC) employs a multi-modality integrated approach combining fluoroscopy for guiding the delivery system, and transesophageal echocardiography (TEE) for intracardiac characterization to guide device selection and monitor procedural complications. Successful implantation of the device is confirmed with contrast-enhanced fluoroscopy and color doppler flow imaging on TEE. TEE is the current gold standard for procedural guidance but requires general anesthesia (GA) to avoid patient motion and discomfort during the procedure. General anesthesia, however, is associated with pulmonary complications and patient discomfort due to endotracheal intubation. Intraprocedural LAAC guidance under local anesthesia or conscious sedation might help mitigate these GA-related disadvantages and has motivated multiple clinical studies, establishing intracardiac echocardiography (ICE) as a safe and feasible alternative to TEE.\n\nThe new generation of NuVision ICE catheter offers a larger imaging volume of 90° x 90° with multiplanar reformatted (MPR) echo views for better visualization of anatomical landmarks and procedural guidance and aid in sizing of the device. This has a potential to improve outcomes and reduce procedure times while lowering healthcare costs.\n\nIn this study, Role of NuVision Intracardiac Echocardiographic (ICE) catheter with Tranesopheal echocardiography (TEE) in predicting intra-procedural outcomes and success of implantation in patients undergoing left atrial appendage occlusion will be assessed.",[44,50],{"label":45,"type":46,"description":47,"interventionNames":48},"Arm 1 - TEE Primary imaging guidance","EXPERIMENTAL","TEE is the primary imaging guidance with 4D ICE is the secondary",[49],"Device: Imaging guidance with TEE and ICE for Left atrial appendage closure",{"label":51,"type":46,"description":52,"interventionNames":53},"Arm 2 - ICE Primary Imaging Guidance","4D ICE is the primary imaging guidance and TEE is the secondary",[49],[55],{"type":56,"name":57,"description":58,"armGroupLabels":59,"otherNames":38},"DEVICE","Imaging guidance with TEE and ICE for Left atrial appendage closure","The occluder size for both LAAC devices will be selected based on the maximal diameter of the LAA orifice following the manufacturer guidelines and using the maximal length of the LAA measured on Echocardiogram. Intraprocedural measurements of the LAA width and depth were acquired on both ICE and TEE per protocol. Both ICE and TEE will be used to assess for any procedural complications prior to insertion of the device delivery sheath.",[45,51],[61],{"name":62,"affiliation":63,"role":64},"Dhanunjaya Lakkireddy, MD","Kansas City Heart Rhythm Institute","PRINCIPAL_INVESTIGATOR",[66],{"name":67,"role":68,"phone":69,"phoneExt":38,"email":70},"Donita Atkins","CONTACT","816-651-1969","datkins@kchrf.com",[72],{"facility":73,"status":74,"city":75,"state":76,"zip":77,"country":78,"countryCode":79,"cosmosGeoPoint":80,"geoPoint":85,"contacts":86},"Kansas City Heart Rhythm Institute - Roe Clinic","RECRUITING","Overland Park","Kansas","66211","United States","US",{"type":81,"coordinates":82},"Point",[83,84],-94.67079,38.98223,{"lat":84,"lon":83},[87,89],{"name":67,"role":68,"phone":69,"phoneExt":38,"email":88},"Datkins@kchrf.com",{"name":62,"role":64,"phone":38,"phoneExt":38,"email":38},{"type":91,"investigatorFullName":38,"investigatorTitle":38,"investigatorAffiliation":38,"oldNameTitle":38,"oldOrganization":38},"SPONSOR","100520837",false,"NCT06061757","Use of 4D-ICE in Conjunction With TEE for Left Atrial Appendage Closure","Use of 4D Intracardiac Echocardiography (4D-ICE) in Conjunction With Transesophageal Echocardiography (TEE) for Left Atrial Appendage Closure (LAAC)","Inclusion Criteria:\n\n* Male\u002FFemales\n* Age:18-80 years\n* History of Atrial Fibrillation\u002FAtrial flutter\n* Will have endocardial Left Atrial Appendage Closure (LAAC) with an Amplatzer Amulet or WATCHMAN FLX device\n\nExclusion Criteria:\n\n* Inability or unwillingness of an individual to give written informed consent\n* Patient not following with our practice after the procedure\n* Complex anatomy for endocardial LAAC\n* Thrombus in LAA\n* Patients with pericardial effusion in pre-op TEE\u002FCCTA\n* Patients currently pregnant (Serum beta HCG completed when labs obtained for the procedure are completed)","ALL","18 Years","80 Years",{"count":102,"type":103},52,"ESTIMATED","INTERVENTIONAL",[106],"NA","This is a prospective, single center, non-randomized study with two parallel arms intended to study if 4D Intracardiac echocardiography (4D-ICE) (Nuvision, Nuvera TM) will provide better visualization of the anatomical landmarks from the larger imaging volume and provide optimal intra procedural guidance similar to Transesophageal echocardiography (TEE) (GE 6VT-D ULTRASOUND TRANSDUCER) for Left atrial appendage closure (LAAC). The study will enroll approximately 52 subjects and will be followed through 12 months.",[109,110],"Atrial Fibrillation","Stroke","2025-08-27",{"date":113,"type":114},"2025-08-28","ACTUAL",{"date":116,"type":114},"2023-05-10",{"date":118,"type":103},"2025-12-31",{"name":5,"class":6},1]